This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Atherosclerosis or Coronary Artery Disease
and you are
between 45 and 80
years old
-
The phase for this study is not defined.
Show me locations

The purpose

Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research (EISNER) is a multi-study research program being conducted at Cedars-Sinai Medical Center. The principal objective of this randomized trial (referred to as "Study 1") is to assess whether coronary artery calcium (CAC) scanning provides clinical benefit thus improving patient outcomes in asymptomatic subjects with intermediate coronary artery disease (CAD) risk. Additionally, the study is designed to assess the value of combining the CAC scan with the Framingham risk score (FRS) and measurements of serum or plasma biomarkers to predict outcomes.

Provided treatments

  • Other: Coronary Artery Calcium (CAC) Scan
Tris trial is registered with FDA with number: NCT00927693. The sponsor of the trial is Cedars-Sinai Medical Center and it is looking for 2137 volunteers for the current phase.
Official trial title:
Early Identification of Subclinical Atherosclerosis Using Non-Invasive Imaging Research (EISNER)